BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6060318)

  • 1. Arsenic as a cause of skin cancer, with notes on its occurrence in Pretoria.
    Schulz EJ
    S Afr Med J; 1967 Sep; 41(33):819-22. PubMed ID: 6060318
    [No Abstract]   [Full Text] [Related]  

  • 2. [Arsenic and the risk for cancer].
    Zachariae H
    Ugeskr Laeger; 1972 Dec; 134(51):2720-1. PubMed ID: 4567610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and histological studies on the problem of drug-induced arsenic tumors].
    Ehlers G
    Z Haut Geschlechtskr; 1968 Sep; 43(18):763-74. PubMed ID: 4886760
    [No Abstract]   [Full Text] [Related]  

  • 4. Arsenic and skin cancer: cocarcinogenicity.
    Spoor HJ
    Cutis; 1976 Nov; 18(5):631-2. PubMed ID: 1022414
    [No Abstract]   [Full Text] [Related]  

  • 5. [Arsenical keratoses and carcinomas].
    Fumal I; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2005 Apr; 60(4):217-21. PubMed ID: 15943097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchial carcinoma of occupational origin (apropos of 2 cases)].
    Kleisbauer JP; Poirier R; Favre R; Laval P
    Mars Med; 1972; 109(11):699-704. PubMed ID: 4662231
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin.
    Kennedy C; Bajdik CD; Willemze R; Bouwes Bavinck JN
    Br J Dermatol; 2005 Jan; 152(1):194-7. PubMed ID: 15656837
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Superficial spreading melanoma" within a psoriasis focus as a delayed sequela following arsenic therapy for psoriasis].
    Grobe JW
    Berufsdermatosen; 1976; 24(6):167-9. PubMed ID: 1016213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenical keratoses in Bangladesh--update and prevention strategies.
    Ruiz de Luzuriaga AM; Ahsan H; Shea CR
    Dermatol Clin; 2011 Jan; 29(1):45-51. PubMed ID: 21095527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cutaneous arsenical cancer in viticultivators in Beaujolais].
    Thiers H; Colomb D; Moulin G; Colin L
    Ann Dermatol Syphiligr (Paris); 1967; 94(2):133-58. PubMed ID: 4228712
    [No Abstract]   [Full Text] [Related]  

  • 11. Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC).
    Guo HR; Yu HS; Hu H; Monson RR
    Cancer Causes Control; 2001 Dec; 12(10):909-16. PubMed ID: 11808710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arsenical keratosis treated by dermatome shaving].
    Kjerkegaard UK; Heje JM; Vestergaard C; Stausbøl-Grøn B; Stolle LB
    Ugeskr Laeger; 2014 May; 176(19):. PubMed ID: 25351674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic.
    Torchia D; Massi D; Caproni M; Fabbri P
    Int J Dermatol; 2008 Jun; 47(6):592-3. PubMed ID: 18477152
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment.
    Salmon-Ehr V; Grosieux C; Potron G; Kalis B
    Dermatology; 1998; 196(2):274. PubMed ID: 9568428
    [No Abstract]   [Full Text] [Related]  

  • 15. The spectrum of cutaneous and internal malignancies in chronic arsenic toxicity.
    Wong ST; Chan HL; Teo SK
    Singapore Med J; 1998 Apr; 39(4):171-3. PubMed ID: 9676149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of squamous cell carcinoma and arsenic keratoses in a patient with vitiligo taking Chinese arsenic medicine.
    Kim HJ; Lee KG; Yi SM; Son SW; Kim IH; Go JU; Park JT; Choi JE
    Int J Dermatol; 2013 Dec; 52(12):1542-3. PubMed ID: 23621373
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of environmental factors excluding ultra violet radiation on the incidence of skin cancer.
    Everall JD; Dowd PM
    Bull Cancer; 1978; 65(3):241-7. PubMed ID: 719179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Puva therapy and carcinogenesis].
    Thomas P; Pannequin C
    Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
    [No Abstract]   [Full Text] [Related]  

  • 19. Infrequent p53 mutations in arsenic-related skin lesions.
    Castrén K; Ranki A; Welsh JA; Vähäkangas KH
    Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic exposure followed by the development of dermatofibrosarcoma protuberans.
    Shneidman D; Belizaire R
    Cancer; 1986 Oct; 58(7):1585-7. PubMed ID: 3742477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.